Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM/(USED IN) OPERATING ACTIVITIES
NET INCOME		$ 125,000,000	$ 736,000,000
Adjustments to reconcile net income to total net cash from operating activities:
Depreciation		66,000,000	71,000,000
Amortization		85,000,000	103,000,000
Impairment		81,000,000
Non-cash lease expense		33,000,000	37,000,000
Net periodic benefit of defined benefit pension plans		(40,000,000)	(42,000,000)
Provision for doubtful receivables from clients		5,000,000	8,000,000
(Benefit from)/provision for deferred income taxes		(17,000,000)	10,000,000
Share-based compensation		22,000,000	27,000,000
Net loss/(gain) on disposal of operations		56,000,000	(359,000,000)
Non-cash foreign exchange gain		(5,000,000)	(2,000,000)
Other, net		(5,000,000)	(24,000,000)
Changes in operating assets and liabilities, net of effects from purchase of subsidiaries:
Accounts receivable		82,000,000	(115,000,000)
Other assets		(22,000,000)	(15,000,000)
Other liabilities		(458,000,000)	(556,000,000)
Provisions		13,000,000	(7,000,000)
Net cash from/(used in) operating activities		21,000,000	(128,000,000)
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to fixed assets and software for internal use		(31,000,000)	(37,000,000)
Capitalized software costs		(15,000,000)	(14,000,000)
Acquisitions of operations, net of cash acquired		(68,000,000)	0
Proceeds from sale of operations		0	696,000,000
Cash and fiduciary funds transferred in sale of operations		(12,000,000)	(216,000,000)
Sale of investments		200,000,000	0
Net cash from investing activities		74,000,000	429,000,000
CASH FLOWS USED IN FINANCING ACTIVITIES
Repayments of debt		(1,000,000)	(508,000,000)
Repurchase of shares		(2,250,000,000)	0
Proceeds from issuance of shares		1,000,000	1,000,000
Net payments from fiduciary funds held for clients		(211,000,000)	(199,000,000)
Payments of deferred and contingent consideration related to acquisitions		(20,000,000)	(17,000,000)
Cash paid for employee taxes on withholding shares		(1,000,000)	0
Dividends paid		(98,000,000)	(92,000,000)
Acquisitions of and dividends paid to non-controlling interests		0	(17,000,000)
Net cash used in financing activities		(2,580,000,000)	(832,000,000)
DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	[1]	(2,485,000,000)	(531,000,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(34,000,000)	(60,000,000)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD	[1]	7,691,000,000	6,301,000,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD	[1]	$ 5,172,000,000	$ 5,710,000,000

[1] The amounts of cash, cash equivalents and restricted cash, their respective classification on the condensed consolidated balance sheets, as well as their respective portions of the increase or decrease in cash, cash equivalents and restricted cash for each of the periods presented have been included in Note 19 — Supplemental Disclosures of Cash Flow Information.